| D011379 |
Prognosis |
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. |
Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses |
|
| D004164 |
Diphosphonates |
Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. |
Bisphosphonate,Bisphosphonates |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D012189 |
Retrospective Studies |
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. |
Retrospective Study,Studies, Retrospective,Study, Retrospective |
|
| D016896 |
Treatment Outcome |
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. |
Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes |
|
| D050071 |
Bone Density Conservation Agents |
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. |
Antiresorptive Agent,Antiresorptive Agents,Antiresorptive Drugs,Bone Resorption Inhibitors,Bone Resorption Inhibitory Agents,Agent, Antiresorptive,Inhibitors, Bone Resorption,Resorption Inhibitors, Bone |
|
| D059266 |
Bisphosphonate-Associated Osteonecrosis of the Jaw |
Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process. |
Bisphosphonate Osteonecrosis,Bisphosphonate-Associated Osteonecrosis,Bisphosphonate-Associated Osteonecrosis of the Jaws,Bisphosphonate-Induced Osteonecrosis of the Jaw,Bisphosphonate-Induced Osteonecrosis of the Jaws,Bisphosphonate-Related Osteonecrosis of the Jaw,Osteonecrosis of the Jaw, Bisphosphonate-Associated,Osteonecrosis of the Jaw, Bisphosphonate-Induced,Osteonecrosis of the Jaw, Bisphosphonate-Related,Osteonecrosis of the Jaws, Bisphosphonate-Associated,Osteonecrosis of the Jaws, Bisphosphonate-Induced,Osteonecrosis of the Jaws, Bisphosphonate-Related,Bisphosphonate Associated Osteonecrosis,Bisphosphonate Associated Osteonecrosis of the Jaw,Bisphosphonate Associated Osteonecrosis of the Jaws,Bisphosphonate Induced Osteonecrosis of the Jaw,Bisphosphonate Induced Osteonecrosis of the Jaws,Bisphosphonate Osteonecroses,Bisphosphonate Related Osteonecrosis of the Jaw,Bisphosphonate-Associated Osteonecroses,Osteonecroses, Bisphosphonate,Osteonecroses, Bisphosphonate-Associated,Osteonecrosis of the Jaw, Bisphosphonate Associated,Osteonecrosis of the Jaw, Bisphosphonate Induced,Osteonecrosis of the Jaw, Bisphosphonate Related,Osteonecrosis of the Jaws, Bisphosphonate Associated,Osteonecrosis of the Jaws, Bisphosphonate Induced,Osteonecrosis of the Jaws, Bisphosphonate Related,Osteonecrosis, Bisphosphonate,Osteonecrosis, Bisphosphonate-Associated |
|
-transparent.png){kind=logo}
